ELECTREON
9.3.2022 09:02:12 CET | Business Wire | Press release
Electreon intends to enter the Finnish market through a collaboration with Destia, the biggest infrastructure service company and a leading provider of charging infrastructure services in Finland. The companies have signed a Memorandum of Understanding (MoU) and as part of the collaboration, the companies will first showcase the wireless charging solution to potential customers by integrating the Electreon wireless system to a commercial electric vehicle (EV). This will give fleet operators the opportunity to experience the benefits of wireless charging in operation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220309005236/en/
The goal of the collaboration is to develop commercial wireless charging projects, where Electreon’s wireless charging system and related operation and maintenance services could be provided as part of Destia’s Charging as a Service solution. Destia offers EV charging solutions for businesses and professional transport, its customers include bus operators, logistics companies, vehicle manufacturers and taxi companies.
Both companies see great potential for wireless charging and wireless Electric Road System (ERS) projects in Finland for different use cases such as buses, delivery trucks, vans, and taxis. ERS deployments can help decrease greenhouse gas emissions from the transport sector and create conditions for electric vehicle commercialization.
This MoU is part of Electreon’s strategy to accelerate its penetration to the Nordic market which has a huge potential as an early adopter of electric mobility. Maher Kasskawo, an e-mobility specialist from one of the Nordic region’s leading public transport operators, has recently joined Electreon as the Nordics business development manager to head the company’s efforts. Mr. Kasskawo has multiple years of experience of Nordic e-bus and charging systems implementation and operation.
“We are very excited to establish the partnership between Destia and Electreon in the Finnish market. Combining Destia’s strength in charging infrastructure and services with Electreon’s seamless technology in both static and dynamic wireless charging will be a competitive solution for many operational businesses within the transportation segment,” says Maher Kasskawo, Business Development Manager, Electreon.
“Wireless charging has great potential especially in the professional transport segment, because it can be fully integrated into infrastructure with no visual impacts and cables. Electreon’s wireless charging technology can complement our EV Charging as a Service solution nicely,” says Jere Jokinen, Head of EV Charging at Destia.
About Electreon
Electreon is the leading provider of wireless charging solutions for electric vehicles (EVs), providing end-to-end charging infrastructure and services to meet the needs and efficiency demands of shared, public and commercial fleet operators and consumers. The company’s proprietary inductive technology dynamically (while in motion) and statically (while stopped) charges EVs quickly and safely, eliminating range anxiety, lowering total costs of EV ownership, and reducing battery capacity needs—making it one of the most environmentally sustainable, scalable, and compelling charging solutions available today. Electreon works with cities and fleet operators on a charging as a service (CaaS) platform that enables cost-effective electrification of public, commercial, and autonomous fleets for smooth and continuous operation. For more information, visit electreon.com .
About Destia
Destia is the biggest infrastructure service company in Finland. Our services cover the entire infrastructure life cycle from design to construction and maintenance. We create urban construction innovations and smart infrastructure solutions that facilitate the movement of people, goods, services and energy as part of northern life. We build tomorrow’s infrastructure with the unique sense of infrastructure of more than 1,600 professionals. Destia’s revenue amounted to approximately MEUR 565 in 2020. Destia is part of the international Colas Group.www.destia.fi/en/
View source version on businesswire.com: https://www.businesswire.com/news/home/20220309005236/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom